[Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary].
暂无分享,去创建一个
G. Veres | K. Farkas | F. Nagy | T. Molnár | M. Papp | Z. Tulassay | P. Lakatos | B. Gasztonyi | M. Szathmári | P. Miheller | J. Banai | L. Lakatos | K. Palatka | T. Szamosi | Z. Végh | Á. Vincze | L. Kiss | G. Horváth | Á. Salamon | P. Golovics | B. Lovász | G. Tóth | M. Szenes | Z. Bartha | Mária Szenes